Industry Insights
Stay informed to stay ahead of your competition with the latest industry trends and insights.
8 стрічок
304 followers
43 статті/тиждень
Navigating the Impact of the Inflation Reduction Act: Assessing Current Realities and Future Trajectory
AbbVie's Skyrizi proves a worthy Humira successor with nearly matching sales ahead of potential UC nod
Gilead writes $2.4B off Trodelvy as CEO underscores ‘time of focused execution’
AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again
327 followers
41 стаття/тиждень
Biotech, Pharmaceutical and Clinical Research News | BioSpace
СтежитиRSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by Feedity)
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by Feedity)
358 followers
47 статей/тиждень
AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline
Tessera Cuts Dozens of Jobs Following Positive Preclinical Results
Reporting from the frontiers of health and medicine
634 followers
74 статті/тиждень
Contains all the PharmaTimes latest World News.
289 followers
10 статей/тиждень
Scientists reveal new method that could reduce waste from drug manufacturing
Two RNA-binding proteins could contribute to cancer therapy development
CMT Research Foundation funds study investigating treatment for CMT1X disease
MPE launches English Myeloma and AL Amyloidosis European Clinical Trial Navigator
Pharmaceuticals news and pharmaceutical industry analysis - FT.com
СтежитиThe latest drugs, health care and pharmaceutical news from the Financial Times, with expert company and industry analysis on FT.com
The latest drugs, health care and pharmaceutical news from the Financial Times, with expert company and industry analysis on FT.com
408 followers
16 статей/тиждень
Science is closing in on the frailties of old age
Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis
Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma
Europe falling behind US and China in pharma innovation, warns AstraZeneca chief
BioPharma
239 followers
23 статті/тиждень
353 followers
3 статті/тиждень
Створіть власну стрічку новин
Готові спробувати?
Спробуйте протягом 14 днів. Платіжна картка не потрібна.